{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:25:47Z","timestamp":1780579547349,"version":"3.54.1"},"reference-count":10,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>We investigated transition from amphetamine\u2010induced psychosis (AIP) to schizophrenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A sample of 28 individuals was identified while hospitalized for AIP. We reviewed their hospital records after six years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During follow\u2010up, seven individuals (25%) died and nine (32%) had moved from the area. Of the remaining 12, four individuals (25%) were diagnosed with schizophrenia. These individuals were, at baseline, characterized by fewer hallucinatory symptoms and more homelessness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion and scientific significance<\/jats:title><jats:p>Hospitalization for AIP was a relatively specific risk factor for schizophrenia and the mortality rate in AIP was high. (Am J Addict 2015;XX:1\u20134)<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajad.12274","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T18:04:01Z","timestamp":1441217041000},"page":"586-589","source":"Crossref","is-referenced-by-count":26,"title":["Amphetamine\u2010induced psychosis: Transition to schizophrenia and mortality in a small prospective sample"],"prefix":"10.1111","volume":"24","author":[{"given":"Sigrid","family":"Medhus","sequence":"first","affiliation":[{"name":"Norwegian Centre for Addiction Research (SERAF) University of Oslo Norway"},{"name":"Lovisenberg Diakonale Hospital Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline Borger","family":"Rognli","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research (SERAF) University of Oslo Norway"},{"name":"Oslo University Hospital Norway"},{"name":"Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research (SERAF) University of Oslo Norway"},{"name":"Kings College London National Addiction Centre London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Holm","sequence":"additional","affiliation":[{"name":"Lovisenberg Diakonale Hospital Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rg","family":"M\u00f8rland","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research (SERAF) University of Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.015784"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m07822"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00196.x"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.09.023"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050225"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.07.037"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.3.196"},{"key":"e_1_2_4_9_1","first-page":"62","article-title":"Differences Between Early\u2010Phase Primary Psychotic Disorders With Concurrent Substance Use and Substance\u2010Induced Psychoses","author":"Caton CLM","year":"2005","journal-title":"Arch Gen Psychiatry."},{"key":"e_1_2_4_10_1","unstructured":"ParksJ SvendsenD SingerP et al. Morbidity and mortality in people with serious mental illness. National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council Alexandria VA; 2006."},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00255.x"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12274","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajad.12274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:49:07Z","timestamp":1696351747000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.12274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/ajad.12274"],"URL":"https:\/\/doi.org\/10.1111\/ajad.12274","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}